Mobile Technologies in Achieving and Maintaining Asthma Control in Children: First Results of MedQuizBot Chat Bot

Background. Anti-inflammatory therapy is used to achieve and maintain asthma control, as well as respiratory function indicators monitoring. Telemedicine technologies can be used for this purpose, and it became particularly essential during the COVID-19 pandemic.

Objective. The aim of the study is to analyze efficacy of the mobile technology MedQuizBot for asthma monitoring, to estimate patient compliance to use such instruments of self-control via the bot and without it, and bot's functioning satisfaction.

Methods. 6-month prospective observational comparative study in patients with asthma from 4 to 17 years old was conducted. All patients were divided into two groups: patients who have used MedQuizBot and patients who have used any other self-control tools. Patients had to enter peakflowmetry data daily and undergo asthma control tests monthly. Patients were able to communicate with their doctor remotely via the chat bot. Main study indicators: determining the efficacy of MedQuizBot in patients with asthma by estimating the compliance to self-control tools at using the bot. Secondary study indicators: estimation of patients satisfaction on using the MedQuizBot and determination of level of asthma control due to the obtained data results.

Results. 41 patients have used MedQuizBot, 27 patients were in the control group. Patients who used the bot more often answered asthma control test questions. Patients over 12 years old have completed the asthma control test less often than young children: ACT was filled on average in 1.5 times, САСТ — 1.8 times. 51% of patients filled in data on peakflowmetry via the new technology, patients from control group did not start the picflowmetry diary. Patients under 12 years old, who filled up the test with their parents, has entered picflowmetry data 7 times more often than adolescents. The asthma was under control in 70% of patients. The data was entered into the system 2.5 times more often during the lockdown period due to COVID-19 pandemic and during the tree flowering season in comparison to other periods of2020. Patients noted the usability of the MedQuizBot and agreed to use it in future.

Conclusion. MedQuizBot is effective in achieving asthma control mainly during the period of need — in case of insufficient control over the disease itself (exposure to pollen allergens, acute respiratory diseases), during the limitations in medical care availability.

1. Global Strategy for Asthma Management and Prevention Updated 2019. Global Initiative on Asthma; 2019. Available online: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf. Accessed on July 9, 2021.

2. Global Strategy for Asthma Management and Prevention Updated2020 [Internet]. Global Initiative on Asthma; 2020. Available onlinefrom: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf. Accessed on July 9, 2021.

3. Pawankar R. Allergic diseases and asthma: a global public health concern and a call to action. The World Allergy Organization Journal. 2014;7(1):12. doi:10.1186/1939-4551-7-12

4. Age-adjusted percentages (with standard errors) of ever having asthma and still having asthma for children under age 18 years, by selected characteristics: United States, 2018. Summary Health Statistics: National Health Interview Survey; 2018. Table C-1a. Available online: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2018_SHS_Table_C-1.pdf. Accessed on July 9, 2021.

5. Statistical collection 2017. (In Russ). [Доступно по: https://minzdrav.gov.ru/ministry/61/22/stranitsa-979/statisticheskie-i-informatsionnye-materialy/statisticheskiy-sbornik-2017-godminzdrav.gov.ru. Ссылка активна на 09.07.2021.

6. Allergologiya i immunologiya. Namazova-Baranova LS, Baranov AA, Khaitov RM; Union of Pediatrician of Russia. Moscow: Pediatr; 2020. 512 p. (Prakticheskie rekomendatsii dlya pediatrov). (In Russ).

7. Pijnenburg M.W., Baraldi E., Brand PL.P, et al. Monitoring asthma in children. Eur Respir J.2015;45(4):906-925. doi: 10.1183/09031936.00088814

8. Farzandipour M, Nabovati E, Sharif R, al. Patient SelfManagement of Asthma Using Mobile Health Applications: A Systematic Review of the Functionalities and Effects. Appl Clin Inform. 2017;8(4):1068-1081. doi: 10.4338/ACI-2017-07-R-0116

9. Nkoy Flory L. Nkoy, Fassl Bernhard A. Fassl, Wilkins Victoria L. Wilkins, et al. Ambulatory Management of Childhood Asthma Using a Novel Self-management Application. Pediatrics. Jun 2019;, 143 (6): e20181711.; doi: 10.1542/peds.2018-1711

10. Whitehead L, Seaton P The effectiveness of self-management mobile phone and tablet apps in long-term condition management: a systematic review. J Med Internet Res. 2016;18 (5):e97. doi: org/10.2196/jmir.4883

11. Namazova-Baranova LS, Vishneva EA, et al. Primary Results of Long-Term Dynamic Monitoring of Children with Bronchial Asthma of Uncontrolled Severe Persistent Course. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2016;13(6):554-559. (In Russ). doi:org/10.15690/pf.v13i6.1668

12. McLean S, Chandler D, Nurmatov U, et al. Telehealthcare for asthma: a Cochrane review. CMAJ. 2011 Aug 9;183(11):E733-E742. doi: 10.1503/cmaj.101146. Epub 2011 Jul 11. PMID: 21746825; PMCID: PMC3153544.

13. Baranov AA, Vishneva EA, Namazova-Baranova LS. Telemedicine — Prospects and Difficulties before a New Development Stage. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2013;10(3):6-11. (In Russ).

14. Klok T, Kaptein AA, Brand PLP Non-adherence in children with asthma reviewed: The need for improvement of asthma care and medical education. Pediatr Allergy Immunol. 2015;26(3):197-205. doi: 10.1111/pai.12362